Mar 03, 09:09
Mar 03, 09:07
80% of moneycontrol users recommend buying Divis Labs.
What's your call on Divis Labs today?
Read 2 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3461.20||2.28||3662.00||2250.00||58,971.83|
|Dec' 14||Sep' 14||Jun' 14||Mar' 14|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||2,368,429|
|Reliance Growth Fund - Retail Plan (G)||1,197,969|
|HDFC Mid-Cap Opportunities Fund (G)||845,835|
|ICICI Prudential Value Discovery Fund (G)||611,629|
Pondy Oxides Recommended on Jan 6th 2015
Recommended price 47.00 | Peak from reco 65.60 38.69%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Divis Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 23,467.42 crore.The company has reported a consolidated sales of Rs 747.62 crore and a Net Profit of Rs 196.43 crore for the quarter ended Mar 2014.
The company management includes Murali K Divi - Chairman & Managing Director, N V Ramana - Executive Director, Madhusudana Rao Divi - Director - Projects, Kiran S Divi - President & Director, G Suresh Kumar - Director, R Ranga Rao - Director, K V K Seshavataram - Ind. Non-Executive Director.
It is listed on the BSE with a BSE Code of 532488 and the NSE with an NSE Code of DIVISLAB.
Its Registered office is at 7-1-77/E/1/303, Divi Towers,,Dharam Karan Road, Hyderabad,Telangana - 500016.
Their Registrars are Karvy Computershare Private Ltd.